Exagen Inc (NASDAQ:XGN)’s traded shares stood at 0.6 million during the last session, with the company’s beta value hitting 1.56. At the close of trading, the stock’s price was $6.60, to imply an increase of 9.45% or $0.57 in intraday trading. The XGN share’s 52-week high remains $7.20, putting it -9.09% down since that peak but still an impressive 74.09% since price per share fell to its 52-week low of $1.71.
Analysts have given a consensus recommendation of Buy for Exagen Inc (XGN), translating to a mean rating of 1.33. Of 2 analyst(s) looking at the stock, 0 analyst(s) give XGN a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy.
Exagen Inc (NASDAQ:XGN) trade information
After registering a 9.45% upside in the last session, Exagen Inc (XGN) has traded red over the past five days. The 5-day price performance for the stock is 9.82%, and 12.82% over 30 days. With these gigs, the year-to-date price performance is 60.98%.
The extremes give us $5 and $5 for target low and target high price respectively. As such, XGN has been trading 24.24% off suggested target high and 24.24% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 19.20% for the past 5-year period. While 2025 is set for a 31.12% return in earnings, projections for the next 5 years are at 49.02% annually.
XGN Dividends
Exagen Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is COWEN AND COMPANY, LLC with 0.89 million shares, or about 4.9035% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $1.62 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Exagen Inc (XGN) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 326.27 shares. This is just over 1.53% of the total shares, with a market valuation of $2.15 million. Data from the same date shows that the other fund manager holds a little less at 141.95, or 0.67% of the shares, all valued at about 0.94 million.
